The FDA is expected to announce this week whether it has approved the epilepsy drug as a monotherapy for partial-onset seizures.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to:
